Current Perspectives on Severe Drug Eruption.
Zhang J, Lei Z, Xu C, Zhao J, Kang X.
Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17.
A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
Anderson HJ, Lee JB.
Medicina (Kaunas). 2021 Sep 1;57(9):925. doi: 10.3390/medicina57090925.
Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
Patel S, John AM, Handler MZ, Schwartz RA.
Am J Clin Dermatol. 2020 Jun;21(3):393-399. doi: 10.1007/s40257-020-00505-3.
Fixed drug eruptions: presentation, diagnosis, and management.
Flowers H, Brodell R, Brents M, Wyatt JP.
South Med J. 2014 Nov;107(11):724-7. doi: 10.14423/SMJ.0000000000000195.
Fixed drug eruption.
Chou YJ, Chang HC.
CMAJ. 2022 Aug 2;194(29):E1036. doi: 10.1503/cmaj.220049.
Dapsone-associated fixed drug eruption.
Garcia D, Cohen PR.
Expert Rev Clin Pharmacol. 2017 Jul;10(7):717-725. doi: 10.1080/17512433.2017.1322508. Epub 2017 Apr 28.
Acute generalized exanthematous pustulosis (AGEP): A review and update.
Szatkowski J, Schwartz RA.
J Am Acad Dermatol. 2015 Nov;73(5):843-8. doi: 10.1016/j.jaad.2015.07.017. Epub 2015 Sep 6.
[Exanthematic drug eruption].
Ziemer M, Livingstone E.
Pathologie (Heidelb). 2025 Mar;46(2):90-100. doi: 10.1007/s00292-025-01418-w. Epub 2025 Feb 18.
Bullous Drug Reactions.
Mockenhaupt M.
Acta Derm Venereol. 2020 Feb 12;100(5):adv00057. doi: 10.2340/00015555-3408.
[Drug eruption].
Tareen A, Bygum A.
Ugeskr Laeger. 2018 Apr 16;180(16):V10170746.
